CVE-2012-0089
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft...
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft Products 9.1 allows remote authenticated users to affect confidentiality via unknown vectors related to ePerformance.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft Products 9.1 allows remote authenticated users to affect confidentiality via unknown vectors related to ePerformance.
- Record
CVE-2012-0089- CVSS 2.0
- 4.0 Medium
AV:N/AC:L/Au:S/C:P/I:N/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft Products 9.1 allows remote authenticated users to affect confidentiality via unknown vectors related to ePerformance.
- Record
CVE-2012-0089- Updated
- 2026-11-02
EUVDEUVD-2012-0127 No score
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft Products 9.1 allows remote authenticated users to affect confidentiality via unknown vectors related to ePerformance.
- Record
EUVD-2012-0127- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-mprx-wcf5-wmxr No score
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft...
Unspecified vulnerability in the PeopleSoft Enterprise HCM component in Oracle PeopleSoft Products 9.1 allows remote authenticated users to affect confidentiality via unknown vectors related to ePerformance.
- Record
GHSA-mprx-wcf5-wmxr- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2012-0089 is a medium vulnerability (CVSS 4.0) in Oracle Peoplesoft Products, published January 18, 2012. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.90%, the 60th percentile. No source names a fixed version.